Suchergebnisse - (Person:"Wang, Tian")

PubPharm (69)

1

Integrated network pharmacology and pharmacological investigations to explore the potential mechanism of Ding-Chuan-Tang against chronic obstructive pulmonary disease

enthalten in: Journal of ethnopharmacology | 2024

von Xu, L. | Wang, T. | Han, Q. | +4

2

Rosmarinic acid mitigates acrylamide induced neurotoxicity via suppressing endoplasmic reticulum stress and inflammation in mouse hippocampus

enthalten in: Phytomedicine : international journal of phytotherapy and phytopharmacology | 2024

von Wang, T. | He, Y. | Li, R. | +3

3

Electroacupuncture attenuates chronic inflammatory pain and depression comorbidity by inhibiting hippocampal neuronal apoptosis via the PI3K/Akt signaling pathway

enthalten in: Neuroscience letters | 2023

von Yang, P. | Chen, H. | Wang, T. | +5

4

LAR Downregulation Protects the Astrocytic U251 and Cocultured SH-SY5Y Cells in a Rotenone-Induced Parkinson's Disease Cell Model

enthalten in: International journal of molecular sciences | 2023

von Zheng, W. | Han, X. | Han, B. | +8

5

Integrated systematic pharmacology analysis and experimental validation to reveal the mechanism of action of Semen aesculi on inflammatory bowel diseases

enthalten in: Journal of ethnopharmacology | 2022

von Li, M. | Wang, F. | Zhang, C. | +4

6

PLK1 as one novel target for the poor prognosis of bladder cancer : An observational study

enthalten in: Medicine | 2022

von Liu, B. | Meng, L. | Su, J. | +7

7

Characteristics and Treatment Outcomes of Pediatric Langerhans Cell Histiocytosis with Thymic Involvement

enthalten in: The Journal of pediatrics | 2022

von Yao, J. | Wang, D. | Ma, H. | +7

8

Leucine alters blood parameters and regulates hepatic protein synthesis via mammalian/mechanistic target of rapamycin activation in intrauterine growth-restricted piglets

enthalten in: Journal of animal science | 2022

von Zhang, J. | Xu, W. | Yang, Y. | +2

9

Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors

enthalten in: Journal of immunology research | 2022

von Zhang, M. | Wang, L. | Liu, W. | +12

10

Novel PARP Inhibitor DDPF-20 Induces DNA Damage and Inhibits Angiogenesis through the PI3K/Akt/VEGF Pathway

enthalten in: Anti-cancer agents in medicinal chemistry | 2022

von Wang, T. | Zhang, D. | Guo, C. | +1

1
2
3
4
5
6
7
Nächster »
[7]